New Sleep Apnea Treatment Improves Depression?
Do you have depressive symptoms as a result of obstructive sleep apnea? If so, there’s something new in the works that could help!
Breakthrough Study Shows Benefits Of Adjunctive L-Methylfolate In The Treatment Of SSRI-Resistant Major Depressive Disorder
New research shows that patients with SSRI-resistant depression can benefit from augmentation therapy with the medical food L-methylfolate. The study, published in the American Journal of Psychiatry, demonstrates the safety superior response and tolerability of L-methylfolate, (available by prescription in the U.S. under the brand name Deplin®) in patients with Major Depressive Disorder (MDD). Approximately two thirds of people living with depression will be unsuccessful with their first round of antidepressant monotherapy...
Online Professional Treatment Would Likely Be Welcomed By Mothers With Postpartum Depression
Mothers suffering from postpartum depression after a high-risk pregnancy would turn to online interventions if available anonymously and from professional healthcare providers, according to researchers from Case Western Reserve University's Frances Payne Bolton School of Nursing and College of Arts and Sciences. Postpartum depression, a moderate to severe depression that can occur after a woman has given birth, affects about 7 to 15 percent of new mothers. The effects can be felt soon after delivery to as long as a year later...
Controlled investigation tests how different treatments can be integrated in depression
This study demonstrates that starting with psychotherapy may be preferable in mildly and moderately depressed outpatients. For patients who receive either PDT or antidepressants, combined therapy after early nonresponse seems to be helpful. Nevertheless, this sequential strategy is not always preferred by patients.
42 Percent Of Antidepressant Response Explained By Common Gene Variants
Antidepressants are commonly prescribed for the treatment of depression, but many individuals do not experience symptom relief from treatment. The National Institute of Mental Health's STAR*D study, the largest and longest study ever conducted to evaluate depression treatment, found that only approximately one-third of patients responded within their initial medication trial and approximately one-third of patients did not have an adequate clinical response after being treated with several different medications...
Biological psychiatry shares progress in identifying genomic predictors of antidepressant response
Antidepressants are commonly prescribed for the treatment of depression, but many individuals do not experience symptom relief from treatment.